Introduction
Graves' disease is an organ-specific autoimmune disease characterized by overstimulation of the thyroid glands by agonistic anti-thyrotropin receptor (TSHR) antibody (thyroid stimulating antibody; TSAb), leading to hyperthyroidism and thyroid enlargement [1, 2] .
Graves' disease has long been assumed to be T helper type 2 (Th2)-dominant, because the disease is autoantibody-mediated. However, this concept has been challenged both in humans and mouse models. TSAb in many [3] , but not all [4] , patients are IgG1, of Th1 subclass in humans. In all the mouse models of Graves' disease so far studied, both Th1 and Th2 immune responses are elicited against the TSHR, and the most monoclonal TSAb are of Th1 subclass [5] .
In addition, the Th1 cytokine IFN- is secreted by splenocytes exposed to TSHR antigen in the T cell recall assay [6] . However, the outcomes of the immune manipulations to alter Th1/Th2 balance are different among distinct mouse models. Thus, Th2 immune response seems to be important in the mouse models using the fibroblasts or B cells expressing the TSHR and MHC class II, whereas Th1 is likely crucial in the models involving genetic immunization using plasmid or adenovirus, or dendritic cells expressing the TSHR [5] . Given all these controversial data, it is possible to speculate that Graves' disease may involve different type of immune response(s) rather than the classical Th1/Th2 immune responses.
IL-17 producing Th17 cells are another CD4
+ effecter T cell lineage recently identified [7, 8] .
Although the pathogenesis of most autoimmune diseases has long been argued on relative balance between Th1 versus (vs.) Th2, the recent studies revealed that Th17 immune responses play a major role in numerous autoimmune diseases, such as multiple sclerosis/experimental autoimmune encephalitis (EAE), uveitis, rheumatoid arthritis, Sjogren's syndrome, myasthenia gravis and psoriasis, all of which had previously been thought to be Th1-diseases [9] .
Moreover we have recently demonstrated that Th17 cells as well as Th1 cells are critical for development of iodine-induced autoimmune thyroiditis in non-obese diabetic (NOD)-H2 h4 mice [9] . The number of Th17 cells has also been recently shown to be increased in Hashimoto's thyroiditis in humans [10] .
This study was therefore conducted to investigate the role for Th17 cells in the pathogenesis of Graves' hyperthyroidism, another thyroid-specific autoimmune disease, in a mouse model with adenovirus coding the TSHR A-subunit (Ad-TSHR289) [11, 12] . Surprisingly, we observed that IL-17 cells are involved in the pathogenesis of Graves' hyperthyroidism in NOD-H2 h4 , but not in BALB/c, mice. Thus, to our knowledge, this is the first report showing that the significance of Th17 in disease pathogenesis is dependent on the mouse genetic backgrounds.
Materials and Methods

Mice used
IL-17 -/-NOD-H2 h4 mice were previously generated [9] . IL-17 -/-BALB/c mice [13] [9, 13] . All the mice were bred in the animal facility at Nagasaki University in a specific pathogen-free condition. Animal care and all experimental procedures were performed in accordance with the Guideline for Animal Experimentation of Nagasaki University with approval of the Institutional Animal Care and Use Committee. Both male and female mice were used for the current study.
Immunization protocols
Construction, amplification, and purification of non-replicative recombinant human adenovirus expressing the human TSHR-A subunit (Ad-TSHR289; kindly provided by Drs.
McLachlan SM and Rapoport B at Cedars-Sinai Medical Center and University of California Los Angeles, CA), and determination of the viral particle concentration were described previously [11, 12] . Six-week-old mice were injected intramuscularly in the quadriceps with 6 100 l PBS containing different doses (10 8 to 10 particles) of Ad-TSHR289 on two occasions at three-weekly intervals, as previously described [11, 12] . Blood, spleens, and the thyroid glands were obtained two and six weeks after the second immunization. Through the whole experiments, the drinking water was not supplemented with iodide in NOD-H2 h4 mice.
Free thyroxine (T 4 ) and anti-TSHR antibody measurements
Serum free T 4 concentrations were measured with a RIA kit (DPC free T 4 kit; Diagnostic Products, Los Angeles, CA). The normal range was defined as the mean ± 3 S.D. of the control untreated mice.
Anti-TSHR antibodies were measured using two different methods. First is a flow cytometry assay as previously described [14] . Briefly, Chinese hamster ovary (CHO) cells stably expressing the TSHR [15] were incubated for 30 min at room temperature with mouse sera (1:100 dilution), followed by incubation for 30 min at 4 C with FITC-conjugated goat anti-mouse IgG (Sigma). Flow cytometry was performed using FACSCanto II (BD Biosciences, San Diego, CA). The normal range was also defined as the mean ± 3 S.D. of the control untreated mice. This assay does not discriminate between stimulating and non-stimulating antibodies. Second is a biological TSAb assay, which measures the stimulating antibodies responsible for hyperthyroidism [17] . Briefly, FRTL5 cells, a normal differentiated rat thyroid epithelial cell line expressing the rat TSHR, were incubated for 2 hrs at 37 C with mouse sera (1:10 dilution), and cAMP released into the medium was measured with a cAMP radioimmunoassay kit (Yamasa, Choshi, Japan) [11] .
Thyroid histology
Thyroid tissues were fixed in 10 % formalin and embedded in paraffin. Five-m-thick sections were prepared and stained with hematoxylin and eosin (H & E).
Cytokine assays
Splenocytes and lymphocytes from the draining lymph nodes were cultured (triplicate aliquots) at 5 x 10 5 cells per well in a 96-well round-bottomed culture plate in the presence or absence of 10 µg/ml TSHR289 protein, as previously described [6] . Four days later, the culture supernatants were collected. The concentrations of various cytokines in these culture supernatants were determined with a Bio-Plex TM Suspension Array System and 23-Plex Panel (IL-1, 1, 2-6, 9, 10, 12 (p40 and p70), 13, 17, Eotaxin, G-CSF, GM-CSF, IFN-, KC, MCP-1, MIP-1 and 1, Rantes and TNF-) (Bio-Rad, Tokyo, Japan).
Statistical analysis
Levels of free T 4 , antibodies and cytokines were analyzed by Student's t-test, and incidences of hyperthyroidism by chi-square test. A p-value less than 0.05 was considered statistically significant. In BALB/c mice immunized with high (10 10 particle/mouse) or low doses (10 9 particles/mouse) of Ad-TSHR289 ( Fig. 1 A and B) , the mean serum free T 4 levels were increased to the comparable levels in IL-17 and 0.66 + 0.37 ng/dl in the low dose group; mean + S.D., n = 9-11), as compared to the control untreated mice (0.52 ± 0.05 or 0.31 ± 0.023), two weeks after the second immunization. The incidences of hyperthyroidism were also similar in three groups (9/10 (90 %), 10/12 (83 %) and 9/11 (82 %), respectively, in the high dose group, and 100 % in the low dose group). To determine whether Th17 cells affect duration of hyperthyroidism, sera were also obtained six weeks after the second immunization in the low dose group. There were no differences in the (Fig. 2 A) .
Results
Serum T 4 and anti-TSHR antibodies in wt and IL-17 gene-disrupted BALB/c and NOD-H2
These antibody titers were not significantly correlated with T 4 levels (r = 0.356 and p > 0.05).
TSAb was determined in the high dose group and found to be increased in most hyperthyroid mice irrespective of IL-17 gene status, which was significantly and positively correlated with T 4 levels (r = 0.62 and p < 0.01, Fig. 2 B) as previously reported [14] , confirming the causative role of TSAb for hyperthyroidism.
As previously reported [11, 12] , the thyroid glands from hyperthyroid BALB/c mice, irrespective of IL-17 gene status or the mouse genetic backgrounds, were diffusely enlarged with cuboidal thyroid epithelial cells, typical features for the hyperfunctioning thyroid glands (Fig. 3) . (Fig. 4 A) Fig. 4 B) . Again these antibody titers were not significantly correlated with T 4 levels (r = 0.118 and p > 0.05).
TSAb was not measured in these NOD-H2 h4 mice because we already showed increased T 4 was mediated by TSAb in this mouse Graves' model ( Fig. 2B and ref. [14] ). Again, the thyroid histology in hyperthyroid NOD-H2 h4 mice was compatible with that seen in hyperthyroid BALB/c mice (see above).
Comparison of cytokine expression profiles in BALB/c and NOD-H2 h4 mice
To seek possible explanation(s) for different responses between BALB/c and NOD-H2 
Discussion
Th17 cells are newly identified effector T cells and are now well known to play a pivotal role in various autoimmune diseases [7, 8] . We have also recently found that, besides Th1 cells, Th17 cells are indispensable for iodine-induced autoimmune thyroiditis in thyroiditis-prone NOD-H2 h4 mice [9] . We here extended our study to Graves' hyperthyroidism, another thyroid-specific autoimmune disease, using a mouse model with adenovirus expressing the autoantigen TSHR that we have previously established [11, 12] .
Our results clearly demonstrate that the consequence of IL-17 gene disruption for induced What genetic factor(s) define the consequences of IL-17 deficiency? In the DSS-induced colitis model mentioned above, differences in the expression patterns of numerous cytokines, such as IL-1, IL-12, IL-17, IFN- etc, in inflamed intestines have been described for these two mouse strains [20] . In contrast, we could not find any differences in cytokine expression profiles in splenocytes and lymphocytes from the draining lymph nodes from BALB/c and NOD-H2 h4 mice irrespective of IL-17 gene status. We can only speculate that disruption of a single cytokine signaling may be much more crucial for disease development in resistant mice than in susceptible mice.
Absence of antigen-specific secretion of IL-17 from splenocytes in the T cell recall assay is reasonable in BALB/c mice, but is somewhat unexpected in NOD-H2 h4 mice because of the critical role of Th17 cells in development of Graves' hyperthyroidism in this mouse strain as mentioned above. The exact reason(s) for these results are at present unclear. However, since Th17 cells are reported to be induced earlier than Th1 cells in some autoimmune diseases in mice [21, 22] , one possibility is that small numbers of Th17 cells participated the very early stage of elicitation of anti-TSHR immune response in NOD-H2 h4 mice. Whatever the reasons, we have previously found the parallel results in the mouse Graves' model we used in this study.
Thus splenocytes from immunized BALB/c mice produced IFN-, but not IL-4, in the response to TSHR289 antigen in the T cell recall assay [6] , whereas both IFN- -/-and IL-4 -/-BALB/c mice are resistant to hyperthyroidism [23] . The former implicates Th1, but the latter both Th1
and Th2, in the pathogenesis of Graves' disease. The opposite was also reported in NOD mice, namely that IL-17 deficiency did not affect the incidence of hyperglycemia, although IL-17 mRNA expression was increased upon development of diabetes [24] . Therefore, the and both Th1 and Th17 cells are pathogenic for iodine-induced autoimmune thyroiditis [9] .
Even in the same diseases, however, it is reported that the relative importance of Th17 is dependent on immunization protocols. Thus Th1 and Th17 cells play a dominant role in uveitis induced by immunization with interphotoreceptor retinoid-binding protein (IRBP)
emulsified with Complete Freund's adjuvant or IRBP-pulsed mature dendritic cells, respectively [26] . Transfer of in vitro generated antigen-specific Th1, Th2 and/or Th17 cells all induce EAE or uveitis [27, 28] . More recently, Th17 cells were demonstrated to convert to Th1 cells in the mouse model of diabetes [29, 30] . Furthermore, as mentioned in the Introduction, relative importance of Th1 or Th2 is different among the distinct Graves' models [5] . From these data, together with our present results, one should be cautious in interpreting the data on Th17 (and also other effector T cells) obtained from animal disease models. The results may be variable depending on immunization protocols, mouse strain, conventional or pathogen-free housing facilities, etc. This assumption also implies that the pathogenesis of a certain autoimmune disease may involve subtle difference in individual humans because each patient has different genetic and environmental backgrounds.
In conclusion, we demonstrate that the role of Th17 immune response in the pathogenesis of Graves' hyperthyroidism in a mouse model is dependent on the genetic background. Our findings and those of others [24] also suggest that the significance of Th17 in a certain disease can not be estimated from analysis of IL-17 expression in the inflamed tissues or splenocytes. 
